Company · CIK 0001359931 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Protara Therapeutics, Inc. · TARA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 SForm 4 → | Jul 1, 4:10 pm EDT | Jesse SheffermanCEO and President, Director | 215,687 | $4.09 | $882,160 | 721,832 | −23.0% | |
| Jun 29, 2026 GMForm 4 → | Jul 1, 4:10 pm EDT | Jesse SheffermanCEO and President, Director | 245,687 | $1.91 | $411,962 | 691,832 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 MForm 4 → | Jul 1, 4:10 pm EDT | Jesse SheffermanCEO and President, Director | 215,687 | — | — | 141,313 | — |